Further delineation of the classical Smith-Lemli-Opitz syndrome phenotype at different patient ages: Clinical and biochemical studies

Clinical Dysmorphology

Volumn 8, Issue 1, 1999, Pages 29-40

  Krajewska Walasek, Małgorzata ^a   Gradowska, Wanda ^a   Ryzko, Józef ^a   Socha, Piotr ^a   Chmielik, Jolanta ^a   Szapłyko, Waldemar ^a   Kasprzyk, Jolanta ^a   Górska, Bozena ^a   Szreter, Mirosława ^a   Wolski, Jan ^a   Rysiewski, Henryk ^a   Małunowicz, Ewa Maria ^a   Gregorek, Hanna ^a   Michałkiewicz, Jacek ^a   Pietraszek, Ewa ^a   Szapłyko, Janina ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

7 dehydrocholesterol; Cholesterol metabolism; Phenotype; Smith Lemli Opitz syndrome

Indexed keywords

7 DEHYDROCHOLESTEROL;

ANTHROPOMETRY; ARTICLE; BLOOD CHEMISTRY; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; DEVELOPMENT; DEVELOPMENTAL DISORDER; EAR MALFORMATION; FAILURE TO THRIVE; FEMALE; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; MALE GENITAL TRACT MALFORMATION; NEUROMUSCULAR DISEASE; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENTIATION DISORDER; SMITH LEMLI OPITZ SYNDROME; SYNDACTYLY; SYNDROME DELINEATION;

AGING; ANTHROPOMETRY; CHOLESTEROL; FEMALE; HUMANS; MALE; PHENOTYPE; SMITH-LEMLI-OPITZ SYNDROME;

EID: 0033012384     PISSN: 09628827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bialer MG, Penchaszadeh VB, Kahn E, Libes R, Krigsman G, Lesser ML (1987). Female external genitalia and Mullerian duct derivatives in a 46,XY infant with the Smith-Lemli-Opitz syndrome. Am J Med Genet 28:723-731.
2. Chambers CM, McLean MP, Ness GC (1997). Smith-Lemli-Opitz syndrome produced in rats with AY 9944 treated by intravenous injection of lipoprotein cholesterol. Am J Med Genet 68:322-327.
3. Clayton PT (1998). Disorders of cholesterol biosynthesis. Arch Dis Child 78:185-189.
4. Cormier-Daire V, Wolf C, Munnich A, Le Merrer M, Nivelon A, Bonneau D, Journel H, Fellmann F, Chevy F, Roux C (1996). Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz and the lethal acrodysgenital syndromes. Eur J Pediatr 155:656-659.
5. Cortner JA, Coates PM, Tershakovec AM (1992). Disorder of lipoprotein metabolism and transport. In: Behrman RE, Kliegman RM, Nelson WE, Vaughan C, editors. Textbook of pediatrics, 14th ed. Philadelphia: WB Saunders.
6. Cunniff C, Kratz LE, Moser A, Natowicz MR, Kelly RI (1997). Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet 68:263-269.
7. Dallaire I. (1969). Syndrome of retardation with urogenital and skeletal anomalies (Smith-Lemli-Opitz syndrome): clinical features and mode of inheritance. J Med Genet 6:13-120.
8. De Die-Smulders C, Fryns J-P (1992). Smith-Lemli-Opitz syndrome: The changing phenotype with age. Genet Counseling 3:77-82.
9. De Die-Smulders C, Van de Meer S, Spaapen L, Fryns JP (1996). Confirmation of defective cholesterol biosynthesis in 2 previously described adult sibs with Smith-Lemli-Opitz syndrome. Genet Counseling 7:161-162.
10. Dehart DB, Lanoue L, Tint GS, Sulik KK (1997). Pathogenesis of malformations in a rodent model for Smith-Lemli-Opitz syndrome. Am J Med Genet 68:328-337.
11. De Leenheer AP, De Bevere VORC, De Ruyter MGM, Claeys AE (1979). Simultaneous determination of retinol and α-tocopherol in human scrum by high-performance liquid chromatography. J Chromatogr 162:408-413.
12. Frantianni CM, Imperato-McGinley J (1994). The syndrome of 5alfa-reductase deficiency. The Endocrinologist 4:302-314.
13. Gregorek H, Imielska D, Górnicki J, Michałkiewicz J, Przeradzka B, Madaliński K (1994). Development of IgG subclasses in healthy Polish children. Arch Immunol Ther Exp 42:377-382.
14. Guzzetta V, De Fabiani E, Galli G, Colombo C, Corso G, Lecora M, Parenti G, Strisciugłio P, Andria G and the Italian SLOS Collaborative Group (1996). Clinical and biochemical screening for Smith-Lemli-Opitz syndrome. Acta Paediatr 85:937-942.
15. Honda A, Tint GS, Salen G, Kelly RI, Honda M, Batta AK, Chen TS, Shefer S (1997). Sterol concentrations in cultured Smith-Lemli-Opitz syndrome skin fibroblasts: Diagnosis of a biochemically atypical case of the syndrome. Am J Med Genet 68:282-287.
16. Hasui M, Hattori K, Taniuchi S, Kohdera U, Nishikawa A, Kinoshita Y, Kobayashi Y (1993). Decreased CD4+ CD29+ (memory T) cells in patients with chronic granulomatous disease. J Infect Dis 167:983-985.
17. Hyett JA, Clayton PT, Moscoso G, Nicolaides KH (1995). Increased first trimester nuclial translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. Am J Med Genet 58:374-376.
18. Imperato-McGinley J, Gautier T, Pichardo M., Shackleton C (1986). The diagnosis of 5α-reductase deficiency in infancy. J Clin Endocrinol Metab 63:1313-1318.
19. Irons M, Elias ER, Tint GS, Salen G, Frieden R, Buie TM, Ampola M (1994). Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. Am J Med Genet 50:347-352.
20. Irons M, Elias ER, Abuelo D, Bull MJ, Greene CL, Johnson VP, Keppen L, Schanen C, Tint GS, Salen G (1997). Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial. Am J Med Genet 68:311-314.
21. Johnson VP (1975). Smith-Lemli-Opitz syndrome: review and report of two affected siblings. Z Kinderheilk 119:221-234.
22. Kelley RI (1995). Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin Chimica Acta 236:45-58.
23. Kolf-Clauw M, Chevy F, Wolf C, Siliart B, Citadelle D, Roux C (1996). Inhibition of 7-dehydrocholesterol reductase by the teratogen AY 9944: a rat model for Smith-Lemli-Opitz syndrome. Teratology 54:115-125.
24. Krajewska-Walasek M, Chrzanowska KH, Gajdulewicz M (1991). Dysmorfic features and diagnosis of Smith-Lemli-Opitz syndrome. In Vogel W, Just W (eds): 3 Tagung der Gesselschaft fur Humangenetic, Abstracts. Ulm: Universitatsverlag Ulm, GmbH, p. 150.
25. Krajewska-Walasek M (1992). One more case of a severe lethal condition resembling the Smith-Lemli-Opitz, type II syndrome. Genet Counseling 2:221 -225.
26. Kurniewicz-Witczakowa R, Miesouricz J, Niedzwiedzka L, Pietrzak M (1983). Rozwoj fixyczny dzieii i intodziexy warszawskiej, warsnawa: In Dz.
27. Lacombe D, Battin J (1993). Gonadal function in Smith-Lemli-Opitz syndrome. Am J Med Genet 45:119.
28. Małunowicz EM, Mitkowska Z, Bal K, Nizankowska-Blaz T, Moszczyńska E, Iwanicka Z, Romer TE (1997). Definitive diagnosis of enzymatic deficiencies of steroidogenesis in at-risk newborns and infants by urinary marker analysis using GC/MS-SIM. Horm Res 48:243-251.
29. Natowicz, MR, Evans JE (1994). Abnormal bile acids in the Smith-Lemli-Opitz syndrome. Am J Med Genet 50:364-367.
30. Pankau R, Partsch C-J, Funda J, Sippell WG (1992). Hypothalamic-pituitary-gonadal function in two infants with Smith-Lemli-Opitz syndrome. Am J Med Genet 43:513-516.
31. Salbert BA, Schwartz ID, Grunt JA (1996). Sex reversal in an infant with Smith-Lemli-Opitz syndrome, type II: Evidence for 5-α reductase deficiency. J Pediatr Endocrinol Metab 9:67-69.
32. Seller MJ, Russell J, Tint GS (1995). Unusual case of Smith-Lemli-Opitz syndrome 'type II'. Am J Med Genet 56:265-268.
33. Seller MJ, Flinter FA, Docherty Z, Fagg N, Newbould M (1997). Phenotypic diversity in the Smith-Lemli-Opitz syndrome. Clin Dysmorphol 6:69-73.
34. Shackleton CHL, (1986). Profiling steroid hormones and urinary steroids (review). J Chromatogr 379:91-156.
35. Smith DW, Lemli L, Opitz JM (1964). A newly recognized syndrome of multiple congenital anomalies. J Pediatr 64:210-217.
36. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, Salen G (1994). Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330:107-113.
37. Tint GS, Salen G, Batta AK, Shefer S, Irons M, Elias ER, Abuelo DN, Johnson VP, Lambert M, Lutz R, Schanen C, Morris CA, Hoganson G, Hughes-Benzie R (1995). Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr 127:82-87.
38. Worthington S, Goldblatt J (1997). Smith-Lemli-Opitz syndrome: further delineation of the phenotype. Clin Dysmorphology 6:263-266.
39. Zahle Østergaard G, Nielsen H, Frus B (1992). Defective monocyte oxidative metabolism in a child with Smith-Lemli-Opitz syndrome. Eur J Pediatr 151:291-294.